Clinical Trial Update: A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining pre-operative endocrine therapy with and without Prometrium (progesterone) in postmenopausal women with early-stage HR-p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PROMETRIUM (PROGESTERONE)

Snippet

Sponsor: St Vincent's Hospital | Conditions: Early-stage Breast Cancer, Hormone Receptor Positive Tumor | Phase 2 | Status: UNKNOWN